Fred Telling
CIK 1382225 · last filed 2026-01-22
Fred Telling is a corporate insider who has filed 78 SEC Form 4 insider transactions across 3 companies since 2007. The most recent filing, for OGEN, was dated Jan 22, 2026. Across all open-market trades the lifetime net is +$146.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $588 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$588
3
78
$146.4K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OGEN | Director | 948 | $0.62 | $588 | $679.7K | 33 | 2026-01-22 |
| CTI BIOPHARMA CORP (CTIC) Delisted | Director | 78,874 | $9.09 | $717.0K | $0 | 8 | 2018-09-20 |
| CTI BIOPHARMA CORP (TRGT) Delisted | Director | 417,490 | — | — | -$533.2K | 29 | 2014-03-07 |
Recent Filings
78 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-01-22 | OGEN | Mixed | −210 | -$198 | EDGAR |
| 2025-12-15 | OGEN | Mixed | −210 | -$198 | EDGAR |
| 2024-12-09 | OGEN | Sell (S) | −3,597 | -$1.3K | EDGAR |
| 2024-09-20 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2023-12-01 | OGEN | Sell (S) | −3,500 | -$12.5K | EDGAR |
| 2023-08-10 | OGEN | Grant (A) | +25,000 | $0 | EDGAR |
| 2022-08-02 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2022-06-27 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2022-06-24 | OGEN | Grant (A) | — | $0 | EDGAR |
| 2022-06-21 | OGEN | Buy (P) | +10,084 | $2.9K | EDGAR |